Fipronil, a highly active and broad spectrum insecticide from the phenyl pyrazole family, is a potent disruptor of the ?-aminobutyric acid (GABA)-gated chloride channel in the insect central nervous system. It owes its insect selectivity to the fact that it is less potent in binding the GABA receptor in mammals. Since its discovery about a decade ago, fipronil has been used against a variety of agricultural, domestic and veterinary insect pests. Despite its wide range of use, however, mammalian metabolism of fipronil has not been extensively investigated. The human metabolism of fipronil has been studied in our laboratory using human liver microsomes (HLM) and cytochrome P450 (CYP) isoforms. CYP3A4 has been identified as the major enzyme catalyzing fipronil metabolism in human. Because of broad substrate specificity of CYP3A4, fipronil may interact with many other CYP3A4 substrates. This study investigated metabolic interactions of fipronil with testosterone or diazepam, two other CYP3A4 substrates. Fipronil was incubated with testosterone or diazepam in HLM and metabolites were analyzed using HPLC. When 1.25, 5 or 20 ?M fipronil incubated with a serial concentrations of testosterone (0-200 ?M), activation of fipronil S-oxidation was observed using HLM as the enzyme source. Inhibition of testosterone 6?-hydroxylation was observed in HLM when incubating testosterone (4, 20, or 100 ?M) with fipronil (0-160 ?M). There were no significant effects of diazepam (0-400 ?M) on metabolism of fipronil (5, 20 or 80 ?M). However, when 6.25, 25 or 100 ?M concentrations of diazepam were incubated with fipronil (0-160 ?M), diazepam hydroxylation was not significantly affected although demethylation of diazepam was inhibited. These results demonstrate that fipronil has the potential to interact with other CYP3A4 substrates
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.